UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3383-3388

2012

Volltextzugriff (PDF)

Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2008-11, Vol.26 (32), p.5165-5169

2008

Volltextzugriff (PDF)

A few pedagogical designs in linear algebra with Cabri and Maple

Linear algebra and its applications, 2010-04, Vol.432 (8), p.2100-2111

Klasa, J.

2010

Volltextzugriff (PDF)

An atomic force microscopy study of the dissolution of calcite in the presence of phosphate ions

Geochimica et cosmochimica acta, 2013-09, Vol.117, p.115-128

2013

Volltextzugriff (PDF)

Mantle cell lymphoma : A clinicopathologic study of 80 cases

Blood, 1997-03, Vol.89 (6), p.2067-2078

1997

Volltextzugriff (PDF)

Eradication of Human Non-Hodgkin’s Lymphoma in SCID Mice by BCL-2 Antisense Oligonucleotides Combined with Low-Dose Cyclophosphamide

Clinical cancer research, 2000-06, Vol.6 (6), p.2492-2500

2000

Volltextzugriff (PDF)

Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-κB, p53, bax, and p27 levels

Molecular cancer therapeutics, 2008-04, Vol.7 (4), p.749-758

2008

Volltextzugriff (PDF)

Randomized Phase III Study of Fludarabine Phosphate Versus Cyclophosphamide, Vincristine, and Prednisone in Patients With Recurrent Low-Grade Non-Hodgkin’s Lymphoma Previously Treated With an Alkylating Agent or Alkylator-Containing Regimen

Journal of clinical oncology, 2002-12, Vol.20 (24), p.4649-4654

2002

Volltextzugriff (PDF)

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines

Blood advances, 2021-03, Vol.5 (5), p.1483-1489

2021

Volltextzugriff (PDF)

Second Malignancies in Patients With Hairy Cell Leukemia in British Columbia: A 20-Year Experience

Blood, 1998-08, Vol.92 (4), p.1160-1164

1998

Volltextzugriff (PDF)

The Spectrum of Lymphoma with 8q24 Aberrations: A Clinical, Pathological and Cytogenetic Study of 87 Consecutive Cases

Leukemia & lymphoma, 2004-03, Vol.45 (3), p.519-528

2004

Volltextzugriff (PDF)

A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172)

Leukemia & lymphoma, 2011-03, Vol.52 (3), p.394-399

2011

Volltextzugriff (PDF)

High-Dose Cyclophosphamide, Carmustine (BCNU), and Etoposide (VP16-213) With or Without Cisplatin (CBV ± P) and Autologous Transplantation for Patients With Hodgkin's Disease Who Fail to Enter a Complete Remission After Combination Chemotherapy

Blood, 1995-07, Vol.86 (2), p.451-456

1995

Volltextzugriff (PDF)

Cytogenetic Analysis in Mantle Cell Lymphoma: A Review of 214 Cases

Leukemia & lymphoma, 2002, Vol.43 (4), p.783-791

2002

Volltextzugriff (PDF)

8q24 translocations in blastic transformation of mantle cell lymphoma

Haematologica (Roma), 2000-11, Vol.85 (11), p.1225

2000

Volltextzugriff (PDF)

Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma

Leukemia research, 2006-04, Vol.30 (4), p.449-457

2006

Volltextzugriff (PDF)

Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung

Journal of clinical oncology, 1991-03, Vol.9 (3), p.499-508

1991

Volltextzugriff (PDF)

Multicolour fluorescence in situ hybridization analysis of t(14;18)‐positive follicular lymphoma and correlation with gene expression data and clinical outcome

British journal of haematology, 2003-09, Vol.122 (5), p.745-759

2003

Volltextzugriff (PDF)

Incidence of second neoplasms in patients with MALT lymphoma: No increase in risk above the background population

Annals of oncology, 1999-03, Vol.10 (3), p.317-321

1999

Volltextzugriff (PDF)

Bcl-3/IgH translocation (14;19)(q32;q13) in Non-Hodgkin's Lymphomas

Leukemia & lymphoma, 2002, Vol.43 (4), p.813-816

2002

Volltextzugriff (PDF)

Targeting the proapoptotic factor Bcl-2 in non-Hodgkin's lymphoma

Oncology (Williston Park, N.Y.), 2004-11, Vol.18 (13 Suppl 10), p.25

Klasa, Richard J

2004

Volltextzugriff (PDF)

Delineation of a minimal region of deletion at 6q16.3 in follicular lymphoma and construction of a bacterial artificial chromosome contig spanning a 6-megabase region of 6q16-q21

Genes chromosomes & cancer, 2004-05, Vol.40 (1), p.60-65

2004

Volltextzugriff (PDF)

Rational approaches to design of therapeutics targeting molecular markers

Hematology, 2001, Vol.2001 (1), p.443-462

2001

Volltextzugriff (PDF)

Concurrent chromosomal alterations at 3q27, 8q24 and 18q21 in B-cell lymphomas

British journal of haematology, 1999-05, Vol.105 (2), p.437-440

1999

Volltextzugriff (PDF)

Treatment of Elderly Hodgkin's Lymphoma Patients with a Novel 5-drug Regimen (ODBEP): A Phase II Study

Leukemia & lymphoma, 2002, Vol.43 (7), p.1395-1402

2002

Volltextzugriff (PDF)

1 – 25 von 186

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(166)
Mit Volltextzugriff
(154)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(85)
Life Sciences & Biomedicine
(79)
Humans
(76)
Female
(54)
Male
(51)
Adult
(48)
Middle Aged
(45)
Oncology
(42)
Biological And Medical Sciences
(41)
Aged
(40)
Medical Sciences
(37)
Hematology
(35)
Aged, 80 And Over
(26)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(24)
Hematologic And Hematopoietic Diseases
(24)
Prognosis
(23)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(22)
Treatment Outcome
(20)
Adolescent
(16)
Antineoplastic Agents
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: Altered Utility in the Modern Era

Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma

A few pedagogical designs in linear algebra with Cabri and Maple

An atomic force microscopy study of the dissolution of calcite in the presence of phosphate ions

Mantle cell lymphoma : A clinicopathologic study of 80 cases

Eradication of Human Non-Hodgkin’s Lymphoma in SCID Mice by BCL-2 Antisense Oligonucleotides Combined with Low-Dose Cyclophosphamide

Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-κB, p53, bax, and p27 levels

Randomized Phase III Study of Fludarabine Phosphate Versus Cyclophosphamide, Vincristine, and Prednisone in Patients With Recurrent Low-Grade Non-Hodgkin’s Lymphoma Previously Treated With an Alkylating Agent or Alkylator-Containing Regimen

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines

Second Malignancies in Patients With Hairy Cell Leukemia in British Columbia: A 20-Year Experience

The Spectrum of Lymphoma with 8q24 Aberrations: A Clinical, Pathological and Cytogenetic Study of 87 Consecutive Cases

A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172)

High-Dose Cyclophosphamide, Carmustine (BCNU), and Etoposide (VP16-213) With or Without Cisplatin (CBV ± P) and Autologous Transplantation for Patients With Hodgkin's Disease Who Fail to Enter a Complete Remission After Combination Chemotherapy

Cytogenetic Analysis in Mantle Cell Lymphoma: A Review of 214 Cases

8q24 translocations in blastic transformation of mantle cell lymphoma

Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma

Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung

Multicolour fluorescence in situ hybridization analysis of t(14;18)‐positive follicular lymphoma and correlation with gene expression data and clinical outcome

Incidence of second neoplasms in patients with MALT lymphoma: No increase in risk above the background population

Bcl-3/IgH translocation (14;19)(q32;q13) in Non-Hodgkin's Lymphomas

Targeting the proapoptotic factor Bcl-2 in non-Hodgkin's lymphoma

Delineation of a minimal region of deletion at 6q16.3 in follicular lymphoma and construction of a bacterial artificial chromosome contig spanning a 6-megabase region of 6q16-q21

Rational approaches to design of therapeutics targeting molecular markers

Concurrent chromosomal alterations at 3q27, 8q24 and 18q21 in B-cell lymphomas

Treatment of Elderly Hodgkin's Lymphoma Patients with a Novel 5-drug Regimen (ODBEP): A Phase II Study

Suchergebnisse filtern